Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation

Status:
Completed

Trial end date:
2005-06-01

Target enrollment:

Participant gender:

To determine whether UK-390,957 is an effective and safe treatment for premature ejaculation.

Phase 2/Phase 3

Pfizer